SCHEMBL6284900

SCHEMBL6284900

CN(C)c1ccc([N+](=O)[O-])cc1CNC(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
ALOX5 P09917 1/20 0.46
ITGA4 P13612 1/20 0.44
ITGB7 P26010 1/20 0.44
MAPT P10636 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
BRD4 O60885 1/20 0.40
MMP1 P03956 2/20 0.40
MMP2 P08253 2/20 0.40
MMP9 P14780 2/20 0.40
MMP8 P22894 2/20 0.40
MMP13 P45452 2/20 0.40
CYP19A1 P11511 1/20 0.39
TP53 P04637 1/20 0.39
HTT P42858 1/20 0.39
MEN1 O00255 1/20 0.39
CRHBP P24387 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12330621 0.84 ALOX5 (0.48) ALDH1A1ALOX5ITGA4ITGB7MAPT
SCHEMBL399470 0.83 ALOX5 (0.47) ALOX5ITGA4ITGB7MAPTNPC1
SCHEMBL5413213 0.83 MEN1 (0.52) ALOX5ITGA4ITGB7MAPTNPC1
SCHEMBL2858710 0.83 ALOX5 (0.47) ALDH1A1ALOX5ITGA4ITGB7MAPT
SCHEMBL6978105 0.82 ALDH1A1 (0.57) ALDH1A1MAPTTP53HTTMEN1
SCHEMBL6681877 0.82 GNRHR (0.49) ALDH1A1ALOX5MAPTSMN1; SMN2MMP1
SCHEMBL4610695 0.81 ALDH1A1 (0.46) ALDH1A1ALOX5ITGA4ITGB7MAPT
SCHEMBL6681796 0.81 ALDH1A1 (0.49) ALDH1A1ALOX5ITGA4ITGB7MAPT
SCHEMBL31455922 0.81 MAPT (0.45) ALDH1A1ALOX5ITGA4ITGB7MAPT
SCHEMBL13172664 0.81 MAPT (0.45) ALDH1A1ALOX5ITGA4ITGB7MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887891-B2 Derivatives of lipoic acid, their preparation, their use as medicaments and the pharmaceutical compositions containing them SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2005-05-03 US disclosed
US-20040019084-A1 New derivatives of lipoic acid, their preparation, their use as medicaments and the pharmaceutical compositions containing them SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION SCIENTIFIQUES (S.C.R.A.S) 2004-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040019084-A1 New derivatives of lipoic acid, their preparation, their use as medicaments and the pharmaceutical compositions containing them NOS1, NOS2, LPO ALDH1A1 320/4885ALOX5 9/4885ITGA4 4833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.